Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Mar;30(3):279-287.
doi: 10.1089/jicm.2023.0043. Epub 2023 Sep 6.

A Randomized Three-Arm Double-Blind Placebo-Controlled Study of Homeopathic Treatment of Children and Youth with Attention-Deficit/Hyperactivity Disorder

Affiliations
Randomized Controlled Trial

A Randomized Three-Arm Double-Blind Placebo-Controlled Study of Homeopathic Treatment of Children and Youth with Attention-Deficit/Hyperactivity Disorder

David Brulé et al. J Integr Complement Med. 2024 Mar.

Abstract

Objectives: Approximately 30% of children diagnosed with attention-deficit/hyperactivity disorder (ADHD), the most prevalent mental health disorder in children worldwide, do not respond to conventional pharmaceutical treatments. Previous studies of homeopathic treatment for ADHD have been inconclusive. The objectives of this study were to determine if there (a) is an overall effect of homeopathic treatment (homeopathic medicines plus consultation) in the treatment of ADHD; (b) are any specific effects the homeopathic consultation alone in the treatment of ADHD; and (c) are any specific effects of homeopathic medicines in the treatment of ADHD. Design: The design was a randomized double-blind placebo-controlled clinical trial. Setting/Location: Toronto, Canada. Subjects: Children aged 6-16 years diagnosed with ADHD. Interventions: Participants were randomized to one of three arms: Arm 1 (Remedy and Consultation); Arm 2 (Placebo and Consultation); or Arm 3 (Usual Care). Outcome Measures: Primary Outcome was the change of CGI-P T score between baseline and 28 weeks. Results: There was an improvement in ADHD symptoms as measured by the Conner 3 Global Index-Parent T-score in the two groups (Arms 1 and 2) that received consultations with a homeopathic practitioner when compared with the usual care control group (Arm 3). Parents of the children in the study who received homeopathic consultations (Arms 1 and 2) also reported greater coping efficacy compared with those receiving usual care (Arm 3). There was no difference in adverse events among the three study arms. Conclusions: In this study, homeopathic consultations provided over 8 months with the use of homeopathic remedy was associated with a decrease in ADHD symptoms in children aging 6-16 years when compared with usual treatment alone. Children treated with homeopathic consultations and placebo experienced a similar decrease in ADHD symptoms; however, this finding did not reach statistical significance when correcting for multiple comparisons. Homeopathic remedies in and of themselves were not associated with any change in ADHD symptoms. Clinical Trial Registration: This trial was registered on ClinicalTrials.gov; NCT02086864.

Keywords: ADHD; attention-deficit/hyperactivity disorder; complementary and alternative medicine; homeopathy; mental health; pediatrics.

PubMed Disclaimer

Conflict of interest statement

D.B. is owner of a commercial homeopathic clinic and retail supplies outlet: Riverdale Homeopathy (1749863 Ontario Ltd.). All other authors declare that they have no competing interests.

Figures

FIG. 1.
FIG. 1.
CONSORT flow diagram. ITT, intention to treat.

Similar articles

References

    1. Polanczyk G, de Lima M, Horta B, et al. . The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 2007;164(6):943; doi: 10.1176/ajp.2007.164.6.942 - DOI - PubMed
    1. Danielson ML, Bitsko RH, Ghandour RM, et al. . Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol 2018;47(2):199–212; doi: 10.1080/15374416.2017.1417860 - DOI - PMC - PubMed
    1. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2004;7:77–97; doi: 10.1017/S1461145703003973 - DOI - PubMed
    1. Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J Paediatr Child Health 2005;41(1–2):23–26; doi: 10.1111/j.1440-1754.2005.00530.x - DOI - PubMed
    1. Hahnemann S. Organon of the Medical Art 6th edition (1842) (transl. O'Reilly). Birdcage Press: Palo Alto; 1996.

Publication types

Associated data